Carpanzano; Anthony E.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Carpanzano; Anthony E..The latest application filed is for "sustained release formulations of nalbuphine".
- Carpanzano; Anthony E. - New Milford CT
- Carpanzano; Anthony E. - Sherman CT
- Carpanzano, Anthony E - Sherman CT
| Patent | Date |
|---|---|
| Sustained release formulations of nalbuphine Grant 10,406,106 - Baichwal , et al. Sept | 2019-09-10 |
| Sustained Release Formulations Of Nalbuphine App 20190117576 - BAICHWAL; Anand R. ; et al. | 2019-04-25 |
| Sustained release formulation of nalbuphine Grant 10,172,798 - Baichwal , et al. J | 2019-01-08 |
| Sustained Release Formulation Of Nalbuphine App 20180042852 - BAICHWAL; Anand R. ; et al. | 2018-02-15 |
| Sustained Release Formulation Of Nalbuphine App 20160263035 - BAICHWAL; Anand R. ; et al. | 2016-09-15 |
| Sustained release formulation of nalbuphine Grant 9,351,938 - Baichwal , et al. May 31, 2 | 2016-05-31 |
| Oral dosage form comprising a therapeutic agent and an adverse-effect agent Grant RE45,822 - Wright, IV , et al. December 22, 2 | 2015-12-22 |
| Sustained release formulation of nalbuphine Grant 9,186,330 - Baichwal , et al. November 17, 2 | 2015-11-17 |
| Sustained Release Formulation Of Nalbuphine App 20140315937 - Baichwal; Anand R. ; et al. | 2014-10-23 |
| Sustained Release Formulation Of Nalbuphine App 20140271852 - BAICHWAL; Anand R. ; et al. | 2014-09-18 |
| Abuse Resistant Opioid Containing Transdermal Systems App 20140199383 - Tavares; Lino ; et al. | 2014-07-17 |
| Sustained release formulations of nalbuphine Grant 8,771,732 - Baichwal , et al. July 8, 2 | 2014-07-08 |
| Sustained release formulation of nalbuphine Grant 8,765,175 - Baichwal , et al. July 1, 2 | 2014-07-01 |
| Sustained Release Formulation Of Nalbuphine App 20130164350 - BAICHWAL; ANAND R. ; et al. | 2013-06-27 |
| Sustained release formulations of nalbuphine Grant 8,394,812 - Baichwal , et al. March 12, 2 | 2013-03-12 |
| Sustained release formulations of nalbuphine App 20090030026 - Baichwal; Anand R. ; et al. | 2009-01-29 |
| Oral dosage form comprising a therapeutic agent and an adverse-effect agent Grant 7,384,653 - Wright, IV , et al. June 10, 2 | 2008-06-10 |
| Sustained release formulations of nalbuphine App 20070048376 - Baichwal; Anand R. ; et al. | 2007-03-01 |
| Oral dosage form comprising a therapeutic agent and an adverse-effect agent App 20050063909 - Wright, Curtis IV ; et al. | 2005-03-24 |
| Abuse resistant opioid containing transdermal systems App 20040241218 - Tavares, Lino ; et al. | 2004-12-02 |
| Oral dosage form comprising a therapeutic agent and an adverse-effect agent App 20030044458 - Wright, Curtis IV ; et al. | 2003-03-06 |
| Sustained release drug-resin complexes Grant 4,996,047 - Kelleher , et al. February 26, 1 | 1991-02-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 